Clinical Trial Update: Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis

View source ↗

Summary

This clinical trial investigates the role of the NLRP3 inflammasome and hypoxia in the severity of osteoporosis in patients with bronchiectasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis
• Osteopenia
• Osteoporosis

Snippet

Sponsor: Chun-Hua Wang, MD | Conditions: Bronchiectasis Adult, Osteoporosis, Osteopenia | Status: UNKNOWN